Whilst researchers try to find biomarkers to forecast ketamine response, clinicians uncover on their own with a conundrum: Which patients really should start with IV ketamine, and which with Spravato? And just how do The 2 compare head to head in true reaction to treatment? showed that a perioperative IV https://peterf555esg3.wikipresses.com/user